Author:
Lundqvist J.,Kastäng F.,Kobelt G.,Jönsson B.
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference17 articles.
1. Magnusson, S.: Treatment of rheumatoid arthritis—does it affect society’s cost for the disease? Br. J. Rheumatol. 35, 791–795 (1996)
2. EFPIA (2002) The European Federation of Pharmaceutical Industries and Associations annual report. http://www.efpia.org/6_publ/annual/Report2002.pdf
3. DiMasi, J.A., Hansen, R.W., Grabowski, H.G., Lasagna, L.: Cost of innovation in the pharmaceutical industry. J. Health Econ. 10, 107–142 (1991)
4. DiMasi, J.A., Hansen, R.W., Grabowski, H.G.: The price of innovation: new estimates of drug development costs. J. Health Econ. 22, 151–185 (2003)
5. Adams, C.P., Brantner, V.V.: Estimating the cost of new drug development: is it really 802 million dollars? Health Aff (Millwood) 25, 420–428 (2006)
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献